Previous 10 | Next 10 |
Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, NJ / ACCESSWIRE / March 14, 2019 / Caladrius Biosciences, Inc. (NASDAQ: CLBS) ("Caladrius" or the "Company"), a late-stage therapeutics development biopharmaceutical company committed to the development of innovative ...
BASKING RIDGE, NJ / ACCESSWIRE / March 14, 2019 / Caladrius Biosciences, Inc. (NASDAQ: CLBS) (''Caladrius'' or the ''Company''), a late-stage therapeutics development biopharmaceutical company committed to the development of innovative products focusing on select cardiovascular indications ...
BASKING RIDGE, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the development of innovative products that have the po...
BASKING RIDGE, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the development of innovative products that have the po...
Gainers: Invacare (NYSE: IVC ) +69% . Reebonz Holding ( RBZ ) +38% . Arcimoto (NASDAQ: FUV ) +35% . Electrameccanica Vehicles (NASDAQ: SOLO ) +21% . CyberArk Software (NASDAQ: CYBR ) +20% . Outlook Therapeutics (NASDAQ: OTLK ) +20% . GWG Holdings (NASDAQ: GWGH ) +19% . Ma...
Thinly traded nano cap Caladrius Biosciences ( CLBS -22.9% ) is down more than double volume, albeit on turnover of only 62K shares, on the heels of preliminary results from a Phase 2a clinical trial evaluating CLB03 in adolescents with recent-onset type 1 diabetes (T1D). More news o...
BASKING RIDGE, N.J., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company with multiple development programs targeting select cardiovascular in...
The following slide deck was published by Caladrius Biosciences, Inc. in conjunction with this Read more ...
BASKING RIDGE, N.J., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company with multiple technology platforms targeting select cardiovascular in...
Basking Ridge, New Jersey, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences to Participate in Upcoming January Conferences BASKING RIDGE, N.J. (January 7, 2019) – Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a lat...
News, Short Squeeze, Breakout and More Instantly...
Caladrius Biosciences Inc. Company Name:
CLBS Stock Symbol:
NASDAQ Market:
Caladrius Biosciences Inc. Website:
BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), announced today that, based upon the final vote count certified by the independent inspector of elections for the annual meeting of ...
NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual Investor Conference to be held on September 15 th . Individual investors, institutional ...
BASKING RIDGE, N.J., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative therapies designed to treat or reverse disease, today announced tha...